The usage of hawthorn preparations has a long history in the traditional treatment of heart failure, which is considered as the inability of a weakened heart to supply peripheral tissues with the required amount of oxygen and nutrients. The leaf, flower, and fruit of the hawthorn, due to the presence of bioactive compounds such as flavonoids, procyanidins, organic acids, amines, etc., are showing a wide range of the effects on the cardiovascular system. The leaf and flower have a positive monograph in Commission E, as well as the EMA monograph, but only for traditional use. Numerous clinical studies have been conducted to evaluate the beneficial effects of dry hawthorn extracts on heart diseases. There are a large number of phytopreparations in various galenic forms on the market trade. According to the recent guidelines, usage of hawthorn preparations as a monotherapy in heart failure is not recommended. Instead, it should be used as an adjunct therapy.
AHA, A. H. A. (1994). Revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Circulation, 90(1), 644–645.
Alirezalu, A., Ahmadi, N., Salehi, P., Sonboli, A., Alirezalu, K., Mousavi Khaneghah, A., Barba, F. J., Munekata, P. E. S., & Lorenzo, J. M. (n.d.). Physicochemical Characterization, Antioxidant Activity, and Phenolic Compounds of Hawthorn (Crataegus spp.) Fruits Species for Potential Use in Food Applications (Vol. 9, Issue 4, p. 436). https://doi.org/10.3390/foods9040436
Arslan, R., & Bektas, N. (2018). Potential Antithrombotic Effect of Crataegus Species. Indian Journal of Pharmaceutical Education and Research, 52(4s), 155–157.
Bisset, N. G., & Wichtl, M. (2001). Herbal Drugs and Phytopharmaceutical. Medpharm GmbH Scientific Publishers, Stuttgart.
Blumenthal, M. (1998). The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, Texas.
Bradley. (2006). British Herbal Compendium – A handbook of scientific information on widely used plant drugs (Vol. 2). British Herbal Medicine Association, Bournemouth.
Cloud, A., Vilcins, D., & McEwen, B. (2020). The effect of hawthorn (Crataegus spp.) on blood pressure: A systematic review (Vol. 7, Issue 3, pp. 167–175). https://doi.org/10.1016/j.aimed.2019.09.002
D.A.B. (1993). Deutscher Pharmacopoea. Deutsches Arzneibuch, 10.
Djordjevic, S. (2017). From Medicinal Plant Raw Material to Herbal Remedies, in: Hany El. In Aromatic and Medicinal Plants – Back to Nature, In Tech (pp. 169–217).
Edwards, J. E., Brown, P. N., Talent, N., Dickinson, T. A., & P.R, S. (2012). A review of the chemistry of the genus Crataegus. Phytochemistry, 79, 5–26.
EMA, E. M. A. (2016a). Committee on Herbal Medicinal Products (HMPC. In Assessment report on Crataegus spp., folium cum flore. Report No.: EMA/HMPC/ 159076/2014.
EMA, E. M. A. (2016b). Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Crataegus spp., folium cum flore.
E.S.C. (2012). Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 33(1787–1847).
Eur, P. (2014a). European Pharmacopoeia. 2010(1432).
Eur, P. (2014b). European Pharmacopoeia. 2013(1220).
Eur, P. (2014c). European Pharmacopoeia. 2010(1865).
Eur, P. (2014d). European Pharmacopoeia. 2008(1864).
Halver, J., Wenzel, K., Sendker, J., Carrillo García, C., Erdelmeier, C. A. J., Willems, E., Mercola, M., Symma, N., Könemann, S., Koch, E., Hensel, A., & Schade, D. (n.d.). Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn? (Vol. 10). https://doi.org/10.3389/fphar.2019.01357
Hänsel, R., Sticher, O., & Steinegger, E. (1999). Pharmakognosie-Phytopharmazie. Springer-Verlag, Berlin, Heidelberg.
Herbal Medicines, P. D. R. (2000). Medical Economics Company, Montvale, New Jersey.
Holubarsch, C. J. F., Colucci, W. S., & Eha, J. (2018). Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review (Vol. 18, Issue 1, pp. 25–36). https://doi.org/10.1007/s40256-017-0249-9
Jančić, R., & Lakušić, B. (2017). Botanika Farmaceutika. , Lento, Belgrade.
Josifović. (1972). Flora of SR Serbia: Vol. IV. SANU, Belgrade.
Kaul, R. (1998). Der Weißdorn: Botanik, Inhaltsstoffe, Qualitätskontrolle, Pharmakologie, Toxikologie und Klinik. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.
Konjević, R., & Tatić, B. (2006). Plant names dictionary. NNK Internacional, Belgrade.
Kovačević, N. (2002). Pharmacognosy Basics, Srpska školska knjiga. Srpska školska knjiga, Belgrade.
Kumar, D., Arya, V., Ali Bhat, Z., Ahmad Khan, N., Prasad, D. N., & D.N. (2012). The genus Crataegus: chemical and pharmacological perspectives. Revista Brasileira de Farmacognosia–Brasilian Journal of Pharmacognosy, 22(5), 1187–1200.
Liste, R. (2007). Arzneimittelinformationen für Deutschland. Council of Europe, Strasbour.
Liste, R. (2020). Arzneimittelverzeichnis für Deutschland. Council of Europe, Strasbour.
Ljubuncic, P., Portnaya, I., Cogan, U., Azaizeh, H., & Bomzon, A. (2005). Antioxidant activity of Crataegus aronia aqueous extract used in traditional Arab medicine in Israel (Vol. 101, Issues 1–3, pp. 153–161). https://doi.org/10.1016/j.jep.2005.04.024
Lund, J. A., Brown, P. N., & Shipley, P. R. (2020). Quantification of North American and European Crataegus flavonoids by nuclear magnetic resonance spectrometry (Vol. 143, p. 104537). https://doi.org/10.1016/j.fitote.2020.104537
Monographs, E. S. C. O. P. (2003). Crataegi folium cum flore, Hawthorn Leaf and Flower.
Monographs, E. S. C. O. P. (2009). Crataegi fructus, Hawthorn Berries. In Suplement 2009, European Scientific Cooperative on Phytotherapy.
Muradoğlu, F., Gürsoy, S., & Yıldız, K. (2019). Quantification Analysis of Biochemical and Phenolic Composition in Hawthorn (Crataegus spp.) Fruits (Vol. 61, Issue 2, pp. 189–194). https://doi.org/10.1007/s10341-018-00415-z
Niederseer, D. (2019). Safety and Effects of Crataegus Extract WS 1442 and Nordic Walking on Lipid Profile and Endothelial Function: a Randomized, Partially Blinded Pilot Study in Overweight Volunteers (Vol. 58). https://doi.org/10.20471/acc.2019.58.04.06
Orhan, I. E. (2018). Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb. Current Medicinal Chemistry, 25(37), 4854–4865.
Petrović, S. (2003). The use of hawthorn preparations in treatment of heart failure, Arhiv za farmaciju. 373–385.
Petrović, S., & Kukić-Marković, J. (2008). Herbal and traditional medicines for treatment of cardiovascular system disorders. Arhiv Za Farmaciju, 58, 419–431.
Sagaradze, V. A., Babaeva, E. Yu., Ufimov, R. A., Trusov, N. A., & Kalenikova, E. I. (2019). Study of the variability of rutin, vitexin, hyperoside, quercetin in “Crataegi folium cum flore” of hawthorn (Crataegus L.) species from Russian flora (Vol. 15, p. 100217). https://doi.org/10.1016/j.jarmap.2019.100217
Sarić. (1986). Flora of SR Serbia. Supplement to the Flora of SR Serbia with New Data on Plant Species, SANU, X(2).
Sarić, M. (1989). Medicinal plants of SR Serbia. SANU, Belgrade.
Schulz, V., Hänsel, R., & Tyler, V. E. (2004). Rational phytotherapy. A physician’s guide to herbal medicine. Springer-Verlag: Berlin, Heidelberg, New York.
Selected Medicinal Plants, W. H. O. M. (1999). (Vol. 2). World Health Organization, Geneva.
Simonović, D. (1959). Botanical dictionary, plant names, Naučno delo. SANU, Belgrade.
Stepanović-Petrović, R., & Micov, A. (2011). Therapy of heart failure. In Pharmacotherapy for pharmacists, Faculty of Pharmacy (pp. 79–103).
Tadić, V., Dobrić, S., Marković, G., Ðordević, S., Arsić, I., Menković, N., & Stević, T. (2008). Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract. Journal of Agricultural and Food Chemistry, 56(17), 7700–7709.
Tasić, S., Šavikin, K., & Menković, N. (2009). A guide through the world of medicinal herbs.
Tassell, M. C., Kingston, R., D., G., M., L., & A, F. (2010). Hawthonn (Crataegus spp.) in the treatment of cardiovascular disease. Pharmacognosy Reviews, 4(7), 32–41.
Tucakov, J. (1996). Herbal treatment - Phytotherapy. Phytotherapy, Prosveta, Belgrade.
Valentine, D. H., Walters, S. M., & Webb, D. A. (1968). Flora Europaea. 2.
Yalçın Dokumacı, K., Uslu, N., Hacıseferoğulları, H., & Örnek, M. N. (2021). Determination of Some Physical and Chemical Properties of Common Hawthorn (Crataegus Monogyna Jacq. Var. Monogyna) (Vol. 63, Issue 1, pp. 99–106). https://doi.org/10.1007/s10341-021-00545-x
Yang, B., & Liu, P. (2012). Composition and health effects of phenolic compounds in hawthorn (Crataegus spp.) of different origins. Journal of the Science of Food and Agriculture, 92(8), 1578–1590.
Yusuf, J. B., & Mericli, A. H. (2016). Pharmacological activities of Crataegus species: A review. International Journal of Multidisciplinary Research and Development, 3(4), 73–76.
Zorniak, M., Szydlo, B., & Krzeminski, T. F. (2017). Craraegus special extract WS 1442: Up-to-date review of experimental and clinical experiences. Journal of Physiology and Pharmacology, 68(4), 521–526.
(N.d.-a).
(N.d.-b).
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
